Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Hyperthermia is also known as HT, thermal therapy, thermotherapy is one of the therapy among surgery, radiation therapy, chemotherapy, gene and immunotherapy. The treatment involves increasing the temperature of the body or a particular region of it over the threshold temperature set at a particular moment by the thermoregulation system. Hyperthermia treatment is usually done with a range of temperatures from 40 to 48°C or similar maintained at a treated site for a period of one hour or more.
The normal tissue are not damaged during hyperthermia if the temperature remains under 111°F. However due to differences in tissue characteristics, higher temperatures may occur resulting in burns, blisters, discomfort, or pain. Therefore key market players are increasing their R&D in new treatment options for patients which is expected to further fueling the demand for hyperthermia cancer treatment market.
The key factor driving the growth of hyperthermia cancer treatment market is rise in prevalence and incidence of cancers is due to several factor including population growth and ageing as well as certain causes of cancer linked with lifestyle and diet. Besides increase in the geriatric population directly affects the global hyperthermia cancer treatment market as elderly population above 65 years and older are fastest?growing age group and is primarily fueled by increasing life expectancy from declines in all-cause mortality because of less smoking, improved screening, and treatment advances which is ultimately fueling the demand for hyperthermia cancer treatment market. However, high cost of hyperthermia treatment procedure is a main factor hampering the growth of the hyperthermia treatment for cancer market.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the hyperthermia cancer treatment market. In addition, complete analysis of changes on the hyperthermia cancer treatment market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. COVID-19 impact on the hyperthermia cancer treatment market was moderate due to decrease in number of patient in hospital owing to safety concern of COVID-19 virus had hamper the growth of hyperthermia cancer treatment market.
The hyperthermia cancer treatment market is segmented based on by device type, by treatment method, by application, by end user and geography.
The hyperthermia cancer treatment can be performed by different device types including infrared hyperthermia devices, microwave hyperthermia devices, ultrasound hyperthermia devices
Microwave hyperthermia device is estimated to have moderate growth during the forecast period owing to providing effective therapeutic conditions with no damage to muscle tissue. The duration of heat treatment is also a major concern in hyperthermia therapy which shows muscle temperature increased to the therapeutic temperature range while maintaining skin temperature. For effective treatment temperatures must be high enough and must be sustained long enough, to damage or kill the cancer cells. However, too high temperature is kept elevated for too long serious side effects may cause harm. Whereas ultrasound hyperthermia device is anticipated to have to witness significant growth in global hyperthermia cancer treatment
The hyperthermia cancer treatment includes treatment method like locoregional method, whole-body
Locoregional method is further bifurcated to continuous hyperthermic peritoneal perfusion (chpp), deep tissue & regional perfusion, external & interstitial, intraluminal or endocavitary methods. Whole body hyperthermia increases the effect of chemotherapy treatments used to treat metastatic cancer that has spread throughout the body. This treatment method is used by investigators to treat cancer cells wherever they are throughout the entire body. This can be achieved by a number of techniques that raise the body temperature to 107-108°F, including the use of thermal chambers similar to large incubators or hot water blankets.
The hyperthermia cancer treatment finds its application in breast cancer, head & neck tumors, liver cancer, prostate cancer, and soft tissue sarcoma
Liver cancer is the mostly treated with hyperthermia cancer treatment. The treatment consist of heating liver tumors by exposing them to a radiofrequency (8±30 MHz) electric field. Whereas soft tissue sarcoma treated with hyperthermia & chemotherapy and ionizing radiation shows synergistic relationship. The rationale for the combination of cytotoxic drugs with regional hyperthermia in the treatment of soft tissue sarcoma is based mostly on clinical evidence that heat increases the killing of tumor cells and enhances the efficacy of some drugs including alkylating agents and platinum analogs. Besides breast cancer is expected to growth at a significant rate during the forecast period.
The hyperthermia cancer treatment has its major end user in ambulatory surgical centers, hospitals & specialty clinics
Hospitals & specialty clinics have major end user of hyperthermia cancer treatment attributing to increasing number of cancer patients around the world. In addition, treatment practices are mostly performed in hospitals, particularly for different treatment method with advanced facilities. Besides patient awareness regarding treatment in hospital is fueling the demand for hyperthermia cancer treatment
Geographically the global hyperthermia cancer treatment market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW)
Asia Pacific is anticipated to witness the highest growth in the global hyperthermia cancer treatment market due to increasing number of new cancer of approximately 100,000 patients per year in the regions. In addition, advanced number of facilities and experienced practitioners as well as treatment available in the region propel the growth of hyperthermia cancer treatment market. China and India has the highest number of cancer cases which further fuel the growth of hyperthermia cancer treatment market. Moreover, growing number of cancer centers, hospital provide opportunity to market key players to introduce less complicated, cost-effective and easily available products specifically developed for emerging economies.
The key players in hyperthermia cancer treatment market are RanD., Andromedic S.r.l., Celsius42 GmbH, Chongqing Haifu Medical Technology Co., Ltd, Gamida, Hydrosun GmbH, InnoMedicus Ltd. , Oncotherm Kft, Pyrexar Medical and Yamamoto Vinita Co., Ltd. among others.
JUNE 2020: ARCI had developed magnetocaloric material for cancer treatment. In magnetic hyperthermia, magnetic nanoparticles are subjected to a few gauss alternating magnetic fields that cause heat losses due to magnetic relaxation. Usually, the temperature required to kill the tumor cells is between 40 and 45°c.
The report analyses the global hyperthermia cancer treatment market based on by device type, by treatment method, by application, by end user and geography. The hyperthermia cancer treatment can be performed by different device types including infrared hyperthermia devices, microwave hyperthermia devices, ultrasound hyperthermia devices. The hyperthermia cancer treatment includes treatment method like locoregional method, whole-body. The hyperthermia cancer treatment finds its application in breast cancer, head & neck tumors, liver cancer, prostate cancer, and soft tissue sarcoma. The hyperthermia cancer treatment has its major end user in ambulatory surgical centers, hospitals & specialty clinics. Geographically the global hyperthermia cancer treatment market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW)
The key players in hyperthermia cancer treatment market are RanD., Andromedic S.r.l., Celsius42 GmbH, Chongqing Haifu Medical Technology Co., Ltd, Gamida, Hydrosun GmbH, InnoMedicus Ltd., Oncotherm Kft, Pyrexar Medical and Yamamoto Vinita Co., Ltd. among others.
Why to buy this report:
